The use of antithyroid drugs in pregnancy and lactation.
about
Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartumPropylthiouracil is teratogenic in murine embryosA categorical structure-activity relationship analysis of the developmental toxicity of antithyroid drugs.Current and emerging treatment options for Graves' hyperthyroidism.Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.Autoimmune thyroid diseases in children.Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancyAplasia cutis congenita after methimazole exposure in utero.Total thyroidectomy in Basedow-Graves' disease treatment: our experienceDeiodinase-mediated thyroid hormone inactivation minimizes thyroid hormone signaling in the early development of fetal skeleton.Different outcomes of neonatal thyroid function after Graves' disease in pregnancy: patient reports and literature review.Management of thyroid disordersBullous aplasia cutis congenita: case report and review of the literature.α-lipoic acid inhibits oxidative stress in testis and attenuates testicular toxicity in rats exposed to carbimazole during embryonic period.Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.Adventures in drug disposition: pas seulement pâté de foie.Graves' hyperthyroidism in pregnancy: a clinical review.2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
P2860
Q24628836-AD8209C1-BAD9-4455-A1BB-B857D1B8F230Q28482407-07EC466E-27EF-4B9F-8F43-25E5D8CEC03EQ33606627-E216D323-31F0-487B-BC71-BD0D0BD2C434Q33635029-6C077E97-367F-4D69-A819-52C88F188630Q33849471-CC4685E3-872C-4AFF-805B-4390A7D57616Q34442814-F5961D4A-BFC7-4B6A-B115-AF2FA56F5FE7Q35160028-A6089537-F130-426E-A3DF-A98472C3DE1BQ35850615-D62F8C29-C52A-4D57-82B1-06BA47BE82D8Q35878562-62AFC98C-3711-4C63-86F4-90A708E16EE9Q36381641-7F35B20E-964D-43E7-8119-449DBC134A3CQ36387553-120B0B2B-2A42-41D9-AEDA-115CAC550E8DQ36586184-2F4CF5BD-028C-4357-B769-C6D14CE18471Q37902879-97DF3F0C-C4E1-4284-B4B4-F0D2BEDB63D1Q41678942-E9D24E1C-C33F-495B-BC27-1AD3243E8CC4Q43605677-B1BDF23B-0B43-4B24-883F-352E276D7850Q48539811-ECAD55C9-BFAD-448A-A8DA-5B2506E3F97CQ55323533-91B1BB18-008E-44A1-B8BB-C2FAC3FD9F76Q57136607-11F999D0-E81C-4DAD-9BA3-F0FA9B3D2838
P2860
The use of antithyroid drugs in pregnancy and lactation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The use of antithyroid drugs in pregnancy and lactation.
@ast
The use of antithyroid drugs in pregnancy and lactation.
@en
type
label
The use of antithyroid drugs in pregnancy and lactation.
@ast
The use of antithyroid drugs in pregnancy and lactation.
@en
prefLabel
The use of antithyroid drugs in pregnancy and lactation.
@ast
The use of antithyroid drugs in pregnancy and lactation.
@en
P356
P1476
The use of antithyroid drugs in pregnancy and lactation.
@en
P2093
P304
P356
10.1210/JC.86.6.2354
P407
P577
2001-06-01T00:00:00Z